Brian K. Halak, 10% Owner at Orexigen Therapeutics, Inc. (OREX), bought 138,100 shares at $7.55 ($1.0M) on 2009-12-17, disclosed to the SEC on 2009-12-21.
Open-market purchase of $1.0M OREX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.55 | 1,677 | $13K | 1.2% |
| 2 | $7.55 | 98,323 | $742K | 71.3% |
| 3 | $7.50 | 639 | $5K | 0.5% |
| 4 | $7.50 | 37,461 | $281K | 27.0% |
| Total | $7.54 avg | 138,100 | $1.0M | 100% |
| Filing → |
| DRNA | SELL | 2018-11-01 | $2.5M | — | Filing → |
| EVOK | SELL | 2015-08-20 | $1K | — | Filing → |
| ATRA | BUY | 2014-10-21 | $20K | — | Filing → |